Topics: Agitation | Substance Use Disorder | Withdrawal

In emergency departments, psychiatrists are often consulted on patients presenting with agitation. In many cases, these patients are under the influence of substances—either from intoxication or withdrawal.

Topics: Co-occurring disorders | Diagnosis | Substance Use Disorder

Just about any psychiatric disorder has a higher rate of addiction comorbidity than in the general population. The rates are even higher in treatment settings—more than 50% of people in addiction treatment settings will have a co-occurring psychiatric problem, and more than 50% in psychiatric settings will typically have a co-occurring Substance Use Disorder.

Topics: Cognitive Behavioral Therapy | Free Articles | Substance Use Disorder

Here’s the basic framework of Cognitive Behavioral Therapy (CBT), how it can be applied to Substance Use Disorders, and ways to incorporate parts of CBT into your daily addiction treatment practice.

Topics: Addiction Treatment | Co-occurring disorders | PTSD | Substance Use Disorder | Trauma

Individuals who have PTSD have a high risk of developing other disorders, including substance use disorders (SUDs). Studies have shown that both in the veteran and non-veteran populations, these numbers are high.

Topics: Addiction Treatment | Naltrexone | Opioid Use Disorder | Research Update

Extended-release (XR) naltrexone (Vivitrol) is FDA approved for opioid use disorder and has shown efficacy in several trials. It works best for patients who have already successfully detoxed from opioids and who are highly motivated to abstain. But what about oral naltrexone?

Topics: Naltrexone | Opioids | Research Update

Extended-release (XR) naltrexone (Vivitrol) is an injectable version of naltrexone that lasts for 4 weeks and is FDA approved for opioid use disorder (OUD). Although effective, there is some concern that XR naltrexone may cause or worsen psychiatric symptoms because of its opioid blockade.

Topics: CME Post-Test

The post-test for this issue is available for one year after the publication date to subscribers only. By successfully completing the test you will be awarded a certificate for 2 CME credits.